Sionna Therapeutics (NASDAQ:SION) Trading Up 5.6% – Should You Buy?

Shares of Sionna Therapeutics, Inc. (NASDAQ:SION) shot up 5.6% during mid-day trading on Monday . The company traded as high as $16.12 and last traded at $14.54. 39,502 shares changed hands during trading, a decline of 81% from the average session volume of 204,829 shares. The stock had previously closed at $13.77.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on SION shares. Guggenheim started coverage on shares of Sionna Therapeutics in a research note on Tuesday. They set a “buy” rating and a $45.00 price target on the stock. Stifel Nicolaus started coverage on shares of Sionna Therapeutics in a research note on Tuesday. They set a “buy” rating and a $32.00 price target on the stock. Finally, TD Cowen started coverage on shares of Sionna Therapeutics in a research note on Tuesday. They set a “buy” rating on the stock.

Sionna Therapeutics Stock Performance

Sionna Therapeutics Company Profile

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.